Jingxing Bai
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
JMJD3 modulates benign prostatic hyperplasia through epigenetic regulation of TGF-β1.
Journal: Cell death & disease
Published: January 05, 2026
Oxidative stress reprograms benign prostatic hyperplasia microenvironments: insights from integrative multi-omics and machine learning.
Journal: Journal of translational medicine
Published: November 07, 2025
Prognostic value of the systemic immune-inflammation index in bladder cancer: an update evidence-based analysis.
Journal: Frontiers in oncology
Published: September 17, 2025
Toxicological Impacts and Mechanistic Insights of Bisphenol a on Clear Cell Renal Cell Carcinoma Progression: A Network Toxicology, Machine Learning and Molecular Docking Study.
Journal: Biomedicines
Published: August 19, 2025
Exploring the association between the ZJU index and overactive bladder: a cross-sectional study based on NHANES 2011-2018.
Journal: Translational andrology and urology
Published: August 08, 2025
Cepharanthine may inhibit the proliferation of prostate cells by blocking the EGFR/PI3K/AKT signaling pathway: comprehensive network analysis, molecular docking, and experimental evaluation.
Journal: Frontiers in pharmacology
Published: June 26, 2025
Global and regional burden of kidney cancer from 1990 to 2021: analysis and future predictions based on global burden of disease study.
Journal: BMC cancer
Published: March 10, 2025
TNF-α modulates cell proliferation via SOX4/TGF-β/Smad signaling in benign prostatic hyperplasia.
Journal: Cell death & disease
Published: December 10, 2024
Synergistic effects of immunotherapy and adjunctive therapies in prostate cancer management.
Journal: Critical reviews in oncology/hematology
Published: November 15, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026